Florida Cancer Research Institute, LLC.

Plantation, Florida 33324

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Breast Neoplasm, Early Stage HER2+ Breast Cancer, Triple-Negative Breast Cancer, Triple-Negative Breast Neoplasms

Studies at this site

• An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide — Completed
• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) — Stopped early